DNA methylation changes in ovarian cancer: Implications for early diagnosis, prognosis and treatment
- 1 April 2008
- journal article
- review article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 109 (1), 129-139
- https://doi.org/10.1016/j.ygyno.2007.12.017
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Clinical Evaluation of E-cadherin Expression and its Regulation Mechanism in Epithelial Ovarian CancerClinical & Experimental Metastasis, 2006
- Epigenetic therapy of cancer: past, present and futureNature Reviews Drug Discovery, 2006
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004
- The history of cancer epigeneticsNature Reviews Cancer, 2004
- Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumorsNature Medicine, 2003
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000
- A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancerOncogene, 1999
- hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agentsOncogene, 1997
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987